XML 33 R12.htm IDEA: XBRL DOCUMENT
v3.24.2.u1

Intangible Assets | 9 Months Ended
--- | ---
Jul. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract] |
Intangible Assets | Note 4. Intangible Assets Intangible assets consisted of the following:
| July 31, 2024 |  | October 31, 2023 |  |
(In millions) | Gross Carrying Amount |  | Accumulated Amortization |  | Gross Carrying Amount |  | Accumulated Amortization |  | Weighted-Average Amortization Period (in years)
Intangible assets with definite lives: |  |  |  |  |  |  |  |  |
Customer relationships | $ | 1,123.0 |  |  | $ | 387.6 |  |  | $ | 1,099.2 |  |  | $ | 345.8 |  |  | 19
Composite intangible assets (1) | 1,101.5 |  |  | 477.9 |  |  | 1,061.9 |  |  | 424.8 |  |  | 15
Technology | 660.0 |  |  | 372.7 |  |  | 494.5 |  |  | 335.4 |  |  | 12
Trademarks | 204.2 |  |  | 87.1 |  |  | 208.9 |  |  | 81.1 |  |  | 15
License and distribution rights and other | 48.0 |  |  | 26.5 |  |  | 51.6 |  |  | 28.0 |  |  | 11
| 3,136.7 |  |  | $ | 1,351.8 |  |  | 2,916.1 |  |  | $ | 1,215.1 |  |  | 16
Less: accumulated amortization and translation | 1,351.8 |  |  |  |  | 1,215.1 |  |  |  |  |
Intangible assets with definite lives, net | 1,784.9 |  |  |  |  | 1,701.0 |  |  |  |  |
Intangible assets with indefinite lives, net (2) | 1.9 |  |  |  |  | 9.3 |  |  |  |  |
Total other intangibles, net | $ | 1,786.8 |  |  |  |  | $ | 1,710.3 |  |  |  |  |
(1) Composite intangible assets primarily consist of technology, trade name, New Drug Application approval and physician relationships. The components are not reflected separately or within the corresponding categories because they are inextricably linked. (2) Intangible assets with indefinite lives include technology and trademarks. Balances include foreign currency translation adjustments. As of July 31, 2024, the estimate of future amortization expenses for intangible assets with definite lives is as follows:
Fiscal Years: | (In millions)
Remainder of 2024 | $ | 48.6 |
2025 | 191.6 |
2026 | 184.0 |
2027 | 169.7 |
2028 | 165.2 |
Thereafter | 1,025.8 |
Total remaining amortization for intangible assets with definite lives | $ | 1,784.9 |
The Company performed its annual impairment assessment in the third quarter of fiscal 2024 and concluded there was no material impairment of goodwill or intangible assets recorded in the nine months ended July 31, 2024. Further information regarding our annual impairment assessment is included in our notes to our consolidated financial statements in our Annual Report on Form 10-K for the fiscal year ended October 31, 2023.

X
- References No definition available. + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for goodwill and intangible assets. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 30 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/350-30/tableOfContent Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/350-20/tableOfContent + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration